Literature DB >> 33019932

ENTPDases from Pathogenic Trypanosomatids and Purinergic Signaling: Shedding Light towards Biotechnological Applications.

Walmir da Silva1, Nancy da Rocha Torres2, Joice de Melo Agripino1, Victor Hugo Ferraz da Silva2, Anna Cláudia Alves de Souza1, Isadora Cunha Ribeiro1, Tatiana Aparecida de Oliveira1, Luciana Angelo de Souza2, Lethicia Kelly Ramos Andrade1, João Victor Badaró de Moraes2, Marcel Arruda Diogo1, Raíssa Barbosa de Castro1, Marcelo Depolo Polêto2, Luis Carlos Crocco Afonso3, Juliana Lopes Rangel Fietto1.   

Abstract

ENTPDases are enzymes known for hydrolyzing extracellular nucleotides and playing an essential role in controlling the nucleotide signaling via nucleotide/purinergic receptors P2. Moreover, ENTPDases, together with Ecto-5´-nucleotidase activity, affect the adenosine signaling via P1 receptors. These signals control many biological processes, including the immune system. In this context, ATP is considered as a trigger to inflammatory signaling, while adenosine (Ado) induces anti-inflammatory response. The trypanosomatids Leishmania and Trypanosoma cruzi, pathogenic agents of Leishmaniasis and Chagas Disease, respectively, have their own ENTPDases named "TpENTPDases," which can affect the nucleotide signaling, adhesion and infection, in order to favor the parasite. Besides, TpENTPDases are essential for the parasite nutrition, since the Purine De Novo synthesis pathway is absent in them, which makes these pathogens dependent on the intake of purines and nucleopurines for the Salvage Pathway, in which TpENTPDases also take place. Here, we review information regarding TpNTPDases, including their known biological roles and their effect on the purinergic signaling. We also highlight the roles of these enzymes in parasite infection and their biotechnological applications, while pointing to future developments. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Biotechnology; Chagas Disease; ENTPDases; Leishmaniasis; Parasites; Purinergic signaling

Mesh:

Substances:

Year:  2021        PMID: 33019932     DOI: 10.2174/1568026620666201005125146

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

Review 1.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

Review 2.  Purinergic modulation of the immune response to infections.

Authors:  Natalia Eberhardt; Gastón Bergero; Yanina L Mazzocco Mariotta; M Pilar Aoki
Journal:  Purinergic Signal       Date:  2022-01-08       Impact factor: 3.765

Review 3.  E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities.

Authors:  Lisvane Paes-Vieira; André Luiz Gomes-Vieira; José Roberto Meyer-Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2021-11-09       Impact factor: 5.293

Review 4.  Development of Novel Anti-Leishmanials: The Case for Structure-Based Approaches.

Authors:  Mohini Soni; J Venkatesh Pratap
Journal:  Pathogens       Date:  2022-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.